
Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxPRkx3b3F0dDd5Vlh6NFpkMkk0WVZmUUJLR1dtaDdGVzRNdHZuSm0xRTUzaWRaY0xiVUoydzcyVzl3ZE5VblVQWjZJd0ZweXJ5UGxFYy1fRmMyeW9WWGUtUGUxT1pzVFF5Zy1YUzJiN1ozeW1fZ0djV0o3UTU1R19hWTFaRGlkVUQteDI2dzVKVnp5VlVNTWRWUGk4VEdLclpvTWgwSGhvZHBjQmxtaWtzcFB1ekttdFh4T2s3QkF4Q0F2UklDYUdvNVRwbEk1cWE2Rm5PVjU5QlVQcHBHNkJr?oc=5" target="_blank">Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies</a>&nbsp;&nbsp;<font color="#6f6f6f">Life Biosciences</font>
